Gastric Cancer

• FDA approval · 2012-07-17
  FDA Approved: FLUOROURACIL — Original Application (Eugia US LLC)

  FDA approved the original ANDA for Fluorouracil by Eugia US LLC, enabling the marketing of a generic fluorouracil chemotherapy product.

• FDA approval · 2011-12-28
  FDA Approved: OXALIPLATIN — Supplemental Application (Winthrop U.S, a business of sanofi-aventis U.S. LLC)

  FDA approved a supplemental application for Oxaliplatin, a drug developed by Winthrop U.S, a business of sanofi-aventis U.S. LLC, indicating…

• FDA approval · 2011-06-29
  FDA Approved: DOCETAXEL — Original Application (Baxter Healthcare Corporation)

  FDA approved the original application for docetaxel by Baxter Healthcare Corporation, marking its initial U.S. approval as a cancer therapy.…

• FDA approval · 2010-10-29
  FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)

  The FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech.

• FDA approval · 2010-10-20
  FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for HERCEPTIN (trastuzumab) submitted by Genentech.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2010-03-05
  FDA Approved: FLUOROURACIL — Original Application (Taro Pharmaceuticals U.S.A., Inc.)

  The FDA approved the original application for a generic fluorouracil product manufactured by Taro Pharmaceuticals U.S.A., Inc.

• FDA approval · 2009-04-08
  FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)

  The FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech, Inc. This action updates the product's label…

• FDA approval · 2008-07-07
  FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for TYKERB (lapatinib) submitted by Novartis Pharmaceuticals Corporation.

• FDA approval · 2008-05-22
  FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for Herceptin (trastuzumab) submitted by Genentech, Inc. The approval updates the product's labeling…

• FDA approval · 2008-01-18
  FDA Approved: HERCEPTIN — Supplemental Application (Genentech, Inc.)

  FDA approved a supplemental application for HERCEPTIN (trastuzumab) from Genentech.